Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind, placebo-controlled study of GTx-024 in postmenopausal females and elderly males
2006-001001-28Phase 2Completed
- Sponsor
- GTx
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Sarcopenia and osteopenia comparing GTx-024 arm with Placebo arm (2 arms). Primary endpoint: Primary endpoint: change in lean muscle mass. Started Mar 2006; status: completed.
02
Drugs
enobosarm
03
Conditions
Sarcopeniaosteopenia
Beyond the preview
Go deeper on 2006-001001-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001001-28.